FDA Approved Drugs: Changes to Approved Drugs
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Administration and Therapy Phases: Overview
Drug Regulation
Prescription, Nonprescription and Orphan Drugs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
1Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Japan. bishalg@med.nagoya-u.ac.jp.
No abstract available in PubMed .